通过调节TRAF3的表达,GIT2直接或间接地对NF-κB途径进行负调节,以促进BMSC的骨质基因分化
Yanna Wang1, Changyuan Wang1, Ying Gong2
1Department of Clinical Pharmacology, College of Pharmacy, Dalian Medical University, 9 West Section, Lvshun South Road, Dalian, Lvshunkou District 116044, China.
Tissue & cell
|February 15, 2025
概括
GIT2促进骨髓中酶干细胞的分化,帮助DNA修复和减少衰老. 这一发现为骨质疏松症和其他衰老疾病提供了新的治疗策略.
科学领域:
- 细胞生物学 细胞生物学
- 遗传学 遗传学是一种遗传学.
- 生物化学 生物化学
背景情况:
- 骨质疏松症 (OP) 是一种常见的衰老疾病,与骨髓中介质干细胞 (BMSC) 差异化有关.
- DNA 损伤和与衰老相关的分泌表型 (SASP) 有助于像OP这样的衰老疾病.
- GIT2是一种DNA修复基因,具有缓解衰老表型的潜力,但其在BMSC分化中的作用尚不清楚.
研究的目的:
- 调查GIT2在BMSCs骨质基因分化中的作用.
- 探索涉及GIT2/TRAF3/NF-κB轴的潜在分子机制.
- 评估GIT2在治疗骨质疏松症方面的潜力.
主要方法:
- 生物信息学分析以确定GIT2及其目标.
- 在体外 (H2O2诱导的BMSCs衰老) 和体内 (卵巢切除诱导的小鼠OP模型) 的研究.
- 使用了微型CT,组织学染色,彗星测定,ELISA,免疫光检测和西式斑点检测.
主要成果:
- GIT2和TRAF3与OP标记有积极的相关性.
- 通过调节TRAF3.3,GIT2抑制了正规和非正规NF-κB通路.
- 通过改善DNA修复和减少衰老,GIT2促进骨质分化.
结论:
- GIT2 是一个关键的调节器,促进骨质性骨细胞的分化.
- GIT2的机制涉及通过TRAF3.3抑制NF-κB信号传递.
- GIT2为骨质疏松症和其他与衰老相关的疾病提供了一个新的治疗点.
更多相关视频
相关概念视频
NF-κB-dependent Signaling Pathway
7.2K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.2K
TGF - β Signaling Pathway
7.2K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.2K
Master Transcription Regulators
6.8K
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
6.8K
PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K
MAPK Signaling Cascades
5.1K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.1K
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K


